(EMAILWIRE.COM, January 11, 2019 ) Report analyzes life science instrumentation market by technology, application, end user, and region. Based on technology, spectroscopy segment is estimated to command largest share of market in 2017. This can be attributed to widespread application of spectroscopy systems across several industries, including pharmaceutical, biopharmaceutical, food & agriculture, environmental testing, & industrial chemistry.
Download Trial Papers of Life Science Instrumentation Market spread across 334 Pages, Profiling 15 Companies and supported with 106 Tables and 76 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=61618 .
The global life science instrumentation market is expected to reach USD 75.24 Billion by 2022 from USD 54.49 Billion in 2017, at a CAGR of 6.7%. The growth of this market is majorly driven by increasing spending on pharmaceutical R&D, rising food safety concerns, technological advancements in analytical instruments, and the availability of funding for life science research.
Life science instrumentation market segmented into research applications, clinical and diagnostic applications. Research applications segment is expected to account for largest share of life science instrumentation market in 2017 owing to launch of technologically advanced life science instruments for drug discovery process, increasing research activities, growth in number of preclinical & clinical trials, & increasing adoption of high-throughput life science instruments in drug development & drug discovery.
Interested in this report, Get More Information on Company Profiles, Forecast, Trends, Analysis with Complete Overview at http://www.whatech.com/market-research/materials-chemicals/543622-life-science-instrumentation-market-worth-us-75-24-billion-by-2022-available-in-new-report .
The life science instrumentation market covers next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The spectroscopy segment is expected to account for the largest share of the global life science instrumentation market in 2017owing to the increasing use of spectroscopy instruments in the drug safety process.
Major players life science instrumentation market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bruker Corporation (US), PerkinElmer, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Horiba Ltd. (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Hitachi High-Technologies Corporation (Japan), Eppendorf AG (Germany), QIAGEN N.V. (Netherlands), GE Healthcare (US), and Merck KGaA (Germany), among others.
Mr. Vishal
+ 18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
